Two Sigma Investments’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.06M | Buy |
267,297
+48,362
| +22% | +$244K | ﹤0.01% | 3231 |
|
|
2025
Q4 | $1.48M | Buy |
218,935
+158,074
| +260% | +$1.11M | ﹤0.01% | 2671 |
|
|
2025
Q3 | $425K | Sell |
60,861
-42,021
| -41% | -$292K | ﹤0.01% | 3064 |
|
|
2025
Q2 | $629K | Sell |
102,882
-221,962
| -68% | -$1.48M | ﹤0.01% | 2481 |
|
|
2025
Q1 | $2.47M | Sell |
324,844
-71,063
| -18% | -$594K | 0.01% | 1606 |
|
|
2024
Q4 | $3.81M | Sell |
395,907
-92,228
| -19% | -$718K | 0.01% | 1272 |
|
|
2024
Q3 | $2.88M | Sell |
488,135
-151,906
| -24% | -$1.01M | 0.01% | 1439 |
|
|
2024
Q2 | $4.44M | Sell |
640,041
-113,699
| -15% | -$799K | 0.01% | 1062 |
|
|
2024
Q1 | $5.8M | Buy |
753,740
+133,677
| +22% | +$1.07M | 0.01% | 899 |
|
|
2023
Q4 | $5.44M | Sell |
620,063
-9,948
| -2% | -$72.8K | 0.01% | 945 |
|
|
2023
Q3 | $4.59M | Buy |
630,011
+146,615
| +30% | +$1.09M | 0.01% | 951 |
|
|
2023
Q2 | $3.2M | Buy |
483,396
+435,984
| +920% | +$2.22M | 0.01% | 1150 |
|
|
2023
Q1 | $162K | Sell |
47,412
-85,664
| -64% | -$332K | ﹤0.01% | 2601 |
|
|
2022
Q4 | $370K | Sell |
133,076
-5,049
| -4% | -$15.1K | ﹤0.01% | 2156 |
|
|
2022
Q3 | $396K | Buy |
138,125
+113,421
| +459% | +$403K | ﹤0.01% | 1875 |
|
|
2022
Q2 | $86K | Sell |
24,704
-173,235
| -88% | -$678K | ﹤0.01% | 2285 |
|
|
2022
Q1 | $932K | Sell |
197,939
-74,056
| -27% | -$362K | ﹤0.01% | 1737 |
|
|
2021
Q4 | $1.64M | Buy |
271,995
+255,795
| +1,579% | +$1.78M | ﹤0.01% | 2103 |
|
|
2021
Q3 | $98K | Buy |
+16,200
| New | +$183K | ﹤0.01% | 4084 |
|
|
2021
Q1 | – | Sell |
-44,751
| Closed | -$406K | – | 4085 |
|
|
2020
Q4 | $406K | Buy |
+44,751
| New | +$322K | ﹤0.01% | 2645 |
|
|
2018
Q4 | – | Sell |
-167,143
| Closed | -$1.03M | – | 3316 |
|
|
2018
Q3 | $1.03M | Buy |
167,143
+43,334
| +35% | +$196K | ﹤0.01% | 1955 |
|
|
2018
Q2 | $791K | Sell |
123,809
-192,376
| -61% | -$1.37M | ﹤0.01% | 2324 |
|
|
2018
Q1 | $2.2M | Buy |
316,185
+230,031
| +267% | +$2.68M | 0.01% | 1454 |
|
|
2017
Q4 | $1.09M | Sell |
86,154
-200,723
| -70% | -$2.45M | ﹤0.01% | 1911 |
|
|
2017
Q3 | $3.41M | Sell |
286,877
-772,639
| -73% | -$11.5M | 0.01% | 1001 |
|
|
2017
Q2 | $15.9M | Buy |
+1,059,516
| New | +$14.1M | 0.06% | 386 |
|
|
2016
Q2 | – | Sell |
-24,400
| Closed | -$213K | – | 3087 |
|
|
2016
Q1 | $213K | Buy |
+24,400
| New | +$203K | ﹤0.01% | 2562 |
|
|
2015
Q3 | – | Sell |
-348,118
| Closed | -$4.04M | – | 2507 |
|
|
2015
Q2 | $4.04M | Buy |
348,118
+241,098
| +225% | +$2.48M | 0.02% | 817 |
|
|
2015
Q1 | $1.11M | Sell |
107,020
-7,933
| -7% | -$74.2K | 0.01% | 1512 |
|
|
2014
Q4 | $1.32M | Buy |
+114,953
| New | +$1.14M | 0.01% | 1237 |
|
|
2014
Q2 | – | Sell |
-83,532
| Closed | -$512K | – | 2267 |
|
|
2014
Q1 | $512K | Buy |
+83,532
| New | +$614K | ﹤0.01% | 1469 |
|
Other funds holding MDXG
EWM
TI
VCM
PCMI
NCM
FLAM
Two Sigma Investments's MDXG Position: Q1 2026 in Review
Two Sigma Investments increased its MiMedx Group (MDXG) stake by 22% in Q1 2026, buying an estimated $244K and bringing the position to 267,297 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3231.
Two Sigma Investments first reported a position in MDXG in Q1 2014 and has held it in 31 quarters since. The position peaked at $15.9M in Q2 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.
- Two Sigma Investments held 267,297 shares of MiMedx Group worth $1.06M as of Q1 2026.
- Two Sigma Investments bought 48,362 MiMedx Group shares in Q1 2026, an estimated $244K.
- MiMedx Group made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3231 holding.
- Two Sigma Investments first reported a position in MiMedx Group in Q1 2014 and has held it in 31 quarters since.
- Two Sigma Investments's MiMedx Group position peaked at $15.9M in Q2 2017.
- 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.